SCHEMBL6184315

SCHEMBL6184315

CN1CCN(Cc2ccc(-c3ccccc3C(N)=O)cc2C(F)(F)F)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.56
KIT P10721 7/20 0.50
KDM4E B2RXH2 2/20 0.50
ALDH1A1 P00352 2/20 0.50
POLB P06746 1/20 0.50
ABL1 P00519 2/20 0.48
BRAF P15056 2/20 0.47
SCN9A Q15858 1/20 0.46
SRC P12931 2/20 0.45
PARP1 P09874 1/20 0.45
CSF1R P07333 1/20 0.45
GAA P10253 1/20 0.45
ATM Q13315 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
FGFR4 P22455 1/20 0.44
EGFR P00533 1/20 0.43
SCD O00767 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29832438 0.87 PDE3B (0.51) KDM4EALDH1A1ABL1SCN9APARP1
SCHEMBL28243207 0.85 NR1H2 (0.51) NR1H2KITKDM4EALDH1A1POLB
SCHEMBL30616117 0.84 NR1H2 (0.52) NR1H2KITKDM4EALDH1A1POLB
Hydrochloric Acid SCHEMBL27678165 0.84 NR1H2 (0.52) NR1H2KITKDM4EALDH1A1POLB
SCHEMBL28222514 0.82 RET (0.47) NR1H2KITABL1PARP1CSF1R
SCHEMBL27997931 0.82 NR1H2 (0.60) NR1H2KITKDM4EALDH1A1POLB
SCHEMBL27910162 0.82 NR1H2 (0.57) NR1H2KITBRAFCSF1REGFR
SCHEMBL29892252 0.82 SCN9A (0.49) NR1H2KITKDM4EALDH1A1POLB
SCHEMBL29557340 0.80 NR1H2 (0.44) NR1H2KITKDM4EALDH1A1ABL1
SCHEMBL2707620 0.79 NR1H2 (0.66) NR1H2KITKDM4EALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109641893-A NOVEL IMIDAZOPYRIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING CANCER 大邱庆北尖端医疗产业振兴财团 2019-04-16 CN claimed
WO-2024036114-A2 COMBINATION THERAPY INCLUDING COX-2 INHIBITOR FOR THE TREATMENT OF CANCER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-02-15 WO disclosed
CN-110194772-B Alkynyl (hetero) aromatic ring compounds for inhibiting protein kinase activity 深圳市塔吉瑞生物医药有限公司 2022-04-05 CN disclosed
WO-2020007234-A1 ALKYNYL(HETERO)AROMATIC COMPOUND FOR INHIBITING PROTEIN KINASE ACTIVITY 深圳市塔吉瑞生物医药有限公司 2020-01-09 WO disclosed
CN-110194772-A For inhibiting (miscellaneous) the fragrant cyclics of the alkynyl of protein kinase activity 深圳市塔吉瑞生物医药有限公司 2019-09-03 CN disclosed
CN-109641893-A NOVEL IMIDAZOPYRIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING CANCER 大邱庆北尖端医疗产业振兴财团 2019-04-16 CN disclosed
CN-105837575-B 3- acetenyl Pyrazolopyrimidine derivative and its preparation method and application 四川大学 2019-01-15 CN disclosed
EP-1572686-A1 ANTHRANILIC ACID AMIDE DERIVATIVES AND THEIR PHARMACEUTICAL USE Novartis AG (CH) 2005-09-14 EP disclosed
WO-2004052884-A1 ANTHRANILIC ACID AMIDE DERIVATIVES AND THEIR PHARMACEUTICAL USE NOVARTIS AG (CH) 2004-06-24 WO disclosed